Response to Chadi A. Calarge re: “Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)”
Restricted accessLetterFirst published online March, 2024
Response to Chadi A. Calarge re: “Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)”
CalargeCA. Re: “Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES)” by Kolitsopoulos et al. J Child Adolesc Psychopharmacol, 2023; 33(7):294; doi: 10.1089/cap.2023.0034
2.
CalargeCA, MillsJA, KaravitiL, et al.Selective serotonin reuptake inhibitors reduce longitudinal growth in risperidone-treated boys. J Pediatr, 2018; 201:245–251; doi: 10.1016/j.jpeds.2018.05.040.
3.
KolitsopoulosF, RamakerS, ComptonSN, et al.Effects of long-term sertraline use on pediatric growth and development: The Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES). J Child Adolesc Psychopharmacol, 2023; 33(1):2–13; doi: 10.1089/cap.2022.0048.
